Hypotension
Heart blocks
SIDE EFFECTS
Flushing Respiratory depression Drowsiness
Muscle weakness
Nausea, vomiting
SPECIAL NOTES:
Use with caution in patients receiving digitalis
Calcium chloride can be used as an antidote if respiratory depression occurs
Pregnancy Class A
USUAL DOSE:
1-4 grams IV given at a rate of 1 gram/minute
MONITOR, REPORT, DOCUMENT
Vitals signs, respiratory, cardiovascular and neurologic status within 5 minutes of administration and every 15 minutes thereafter.
END
DRUG PROFILE
Initial Date: 12/05/2002
|
Last /Review, Revision: 11/08
|
Profile Number: 027
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
METHYLPREDNISOLONE (SOLU-MEDROL)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Adrenal corticosteroid
INDICATIONS FOR USE
Decrease inflammation
Suppress immune reactions (e.g. anaphylaxis)
Spinal cord injuries (new)
CONTRAINDICATIONS
Allergy
Children Less than 2 years of age
Tuberculosis or AIDS
Use with caution in patients with a history of peptic ulcer, congestive heart failure, liver or kidney disease, diabetes mellitus
SIDE EFFECTS
Insomnia
Heartburn
Mood swings
Delayed wound healing
Increased susceptibility to infection
Hypertension
SPECIAL NOTES:
Provided in a Mix-O-Vial. Follow manufacturer’s recommendations to reconstitute
Pregnancy category C
USUAL DOSE
125 mg (adult)
2 mg/kg (pediatric), maximum dose 125 mg
30 mg/kg over 2-3 minutes for spinal cord injuries
MONITOR, REPORT, DOCUMENT
Continuous ECG
Vital signs before and within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 12/05/2002
|
Last /Review, Revision: 11/08
|
Profile Number: 028
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
METOCLOPRAMIDE (REGLAN)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Antiemetic, GI stimulant (increases peristalsis)
INDICATIONS FOR USE
Nausea and vomiting (adults)
CONTRAINDICATIONS
Allergy to metoclopromide or procaine/procainamide
History of pheochromocytoma, seizure disorder, kidney or liver failure, Parkinson’s disease, GI bleeding, bowel obstruction
SIDE EFFECTS
Fatigue
Drowsiness
Dystonic reactions (muscle spasm, fixed postures, strange movement patterns
SPECIAL NOTES:
Diphenhydramine (Benadryl) can be used to treat dystonic reactions
Pregnancy category B
USUAL DOSE
10 mg over 1-2 minutes IV bolus (adults)
MONITOR, REPORT, DOCUMENT
Continuous ECG
Vital signs before and within 5 minutes after administration
END
DRUG PROFILE
-
Initial Date: 1/5/05
|
Last Review/Revision: 12/08
|
Profile Number: 029
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
ACTIVATED CHARCOAL (WITHOUT SORBITOL)
-
Approved for use by
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
XX
|
XX
|
XX
|
XX
|
DRUG ACTION:
Absorbs ingested toxins and toxicants
INDICATIONS FOR USE
Suspected orally ingested overdose in patients with normal level of consciousness
CONTRAINDICATIONS
Depressed level of consciousness
Active vomiting
SIDE EFFECTS
Constipation
Nausea, vomiting
Bowel obstruction
Pulmonary aspiration
Corneal abrasions may occur if charcoal inadvertently gets into the eyes
SPECIAL NOTES:
Consider contact with Poison Control Center
Rapid ingestions may invoke vomiting. Be prepared to clear and monitor the patient’s airway
Container must be shaken thoroughly and frequently during administration.
Continue to assess patient and be prepared to manage airway difficulties.
Pregnancy category D
USUAL DOSE
Adults and children: 1 gram activated charcoal/kg of body weight, administered orally
Usual adult dose: 25-50 grams
Usual child dose: 12.5-25 grams
MONITOR, REPORT, DOCUMENT
Changes in level of consciousness
Vital signs within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 1/1/05
|
Last Review/Revision: 11/08
|
Profile Number: 030
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
BUTORPHANOL TARTRATE (STADOL)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Synthetic narcotic analgesic, central nervous system depressant
INDICATIONS FOR USE
Moderate to severe pain
CONTRAINDICATIONS
Head, chest, abdominal trauma
Allergy to the drug
Undiagnosed abdominal pain
CHF, Myocardial infarction
SIDE EFFECTS
Respiratory depression Altered level of consciousness Hypotension Bradycardia Nausea/vomiting
SPECIAL NOTES:
May precipitate withdrawal in addicts
Can be reversed with naloxone (Narcan)
Pregnancy category C
USUAL DOSE:
0.5-2 mg slow IV bolus over 2-3 minutes (adults)
MONITOR, REPORT, DOCUMENT
Vital signs, response to medication
END
DRUG PROFILE
Initial Date: 10/30/2004
|
Last Review/Revision: 11/08
|
Profile Number: 031
|
Service Director’s
Signature
|
|
Medical Director’s
Signature
|
|
The following is the basic information and guideline for use of:
DILTIAZEM (Cardizem)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Calcium Channel Blocker, Calcium Channel Antagonist
INDICATIONS FOR USE:
Atrial Fibrillation with rapid ventricular rate (greater than 160/minute)
Atrial Flutter with rapid ventricular rate (greater than 160/minute)
Multifocal Atrial Tachycardia with rapid ventricular rate (greater than 160/minute)
Paroxysmal Supraventricular Tachycardia (PSVT) with rapid ventricular rate (greater than 160/minute)
CONTRAINDICATIONS:
Sick Sinus Syndrome
Second or Third- Degree AV block
Severe Hypotension
Cardiogenic Shock
Atrial Fibrillation or Atrial Flutter associated with WPW syndrome
Use of IV Beta Blockers
Ventricular Tachycardia
Wide-Complex Tachycardia of unknown origin
SIDE EFFECTS
Chest Pain Ventricular Dysrhythmias
Bradycardia First and Second- Degree AV blocks
Congestive Heart Failure Nausea and Vomiting
Syncope Atrial Flutter
SPECIAL NOTES:
For use with on-line medical control order only (no standing orders)
Pregnancy Safety- Category C (generally considered safe for use during labor)
Use with caution in patients with impaired renal or hepatic function
Hypotension may occasionally result – usually related to rate of delivery
PVC’s may be present on conversion of PSVT to sinus rhythm
Treatment of resultant hypotension: Calcium Chloride (100mg/ml) 2mg/kg IVP (usually 2ml)
USUAL DOSE:
Adult: Start with 10mg dose IVP over 2 min. Re-evaluate, Repeat if needed
Maximum initial dose = 0.25mg/kg (usual concentration = 25mg/5ml)
Pediatric: Not recommended
MONITOR, REPORT, DOCUMENT
Rhythm strip/12 Lead EKG before administration and after administration
Vital signs within 5 min of administration
Watch for Bradycardia and Hypotension, and any Heart Blocks
END
DRUG PROFILE
Initial Date: 1/1/05
|
Last /Review, Revision: 11/08
|
Profile Number: 032
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
ETOMIDATE (AMIDATE)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Non-barbiturate hypnotic, sedative
Onset of action within 60 seconds, duration of action 3-5 minutes
INDICATIONS FOR USE
Short acting anesthesia as premedication for endotracheal intubation, cardioversion or pacing
CONTRAINDICATIONS
Labor, delivery
Allergy to the drug
SIDE EFFECTS
Nausea, vomiting
Hypo- or hypertension
Tachy- or bradycardia, arrhythmias
Respiratory depression
Involuntary muscle movements
SPECIAL NOTES:
Use with caution is elderly patients
Not recommended for pediatric patients
Pregnancy category C, unknown excretion in breast milk
USUAL DOSE
0.2-0.3 mg/kg IV bolus into a free-flowing IV line
Not recommended for children under age 10
MONITOR, REPORT, DOCUMENT
Continuous ECG
Vital signs before and within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 1/1/05
|
Last Review/Revision: 11/08
|
Profile Number: 033
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
FENTANYL CITRATE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Short acting narcotic analgesic
Central Nervous System depressant
INDICATIONS FOR USE
Moderate to Severe pain
Adjunct to rapid sequence intubation (RSI)
CONTRAINDICATIONS
Hypotension (if less than 90mm Hg or greater than 60mm Hg below baseline consider contacting medical control)
Allergy to the drug
SIDE EFFECTS
Respiratory depression Dizziness Altered level of consciousness Bradycardia
SPECIAL NOTES:
Can be reversed with naloxone
Use with caution in patients with respiratory, liver or kidney disease, seizure disorder
Protect from light
USUAL DOSE:
Titrate to effect
25-100 micrograms slow IV over 2-3 minutes (adult)
1 mcg/kg slow IV over 2-3 minutes (pediatric moderate to severe pain)
Contact medical control for additional dosing
Intranasal dosing same as IV dosing
MONITOR, REPORT, DOCUMENT
Vital signs, response to medication
END
DRUG PROFILE
Initial Date: 1/1/05
|
Last Review/Revision: 12/08
|
Profile Number: 034
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
HYDROMORPHONE (DILAUDID)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Long acting narcotic analgesic, central nervous system depressant
INDICATIONS FOR USE
Moderate to severe pain
CONTRAINDICATIONS
Allergy to the drug
Head, chest, abdominal trauma
Undiagnosed abdominal pain
SIDE EFFECTS
Headache Hypotension Bradycardia Respiratory depression Nausea/vomiting
SPECIAL NOTES:
Addictive
Can be reversed with naloxone
Can precipitate seizures in patients with convulsive disorders
Use with caution in patients with respiratory disease/depression
Pregnancy category C
USUAL DOSE:
0.5 - 1 mg slow IV bolus over 2-3 minutes (1 mg hydromorphone is equivalent to 7.5 mg morphine)
Not recommended for pediatric patients
MONITOR, REPORT, DOCUMENT
Vital signs, response to medication
END
DRUG PROFILE
Initial Date: 1/1/05
|
Last Review/Revision: 11/08
|
Profile Number: 035
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
KETOROLAC (TORADOL)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
| |